Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng Hu

Showing results (1301-1310 of 1,327) with videos related to

Pageof 133
Sort By:
Journal of Hematology & Oncology|February 7, 2025
Anti-LAG-3 antibody LBL-007 plus anti-PD-1 antibody toripalimab in advanced nasopharyngeal carcinoma and other solid tumors: an open-label, multicenter, phase Ib/II trialGang Chen, Dong-Chen Sun, Yi Ba, et al.
Scientific Reports|February 17, 2018
Polygonum aviculare L. extract and quercetin attenuate contraction in airway smooth muscleXi Luo, Lu Xue, Hao Xu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2021
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 TrialShengxiang Ren, Jianhua Chen, Xingxiang Xu, et al.
Cancer Discovery|June 8, 2021
MET Amplification Attenuates Lung Tumor Response to Immunotherapy by Inhibiting STINGYong Zhang, Qifan Yang, Xiangyu Zeng, et al.
Liver Cancer|March 6, 2023
Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 TrialZhenggang Ren, Michel Ducreux, Ghassan K Abou-Alfa, et al.
Cancer Cell|February 28, 2025
Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trialCheng Xu, Guan-Qun Zhou, Wen-Fei Li, et al.
Molecular Cancer|January 4, 2022
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trialTao Jiang, Jianhua Chen, Xingxiang Xu, et al.
Genome Biology|October 31, 2023
MGA-seq: robust identification of extrachromosomal DNA and genetic variants using multiple genetic abnormality sequencingDa Lin, Yanyan Zou, Xinyu Li, et al.
Med (New York, N.Y.)|February 14, 2026
Patient-reported outcomes from a phase 2 PLATINUM trial of nivolumab combination therapy sparing concurrent cisplatin in nasopharyngeal carcinomaCheng Xu, Ze-Qi Lin, Yu-Zhe Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2023
HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non-Small Cell Lung CancerTao Jiang, Qiqi Jin, Jiahao Wang, et al.
Pageof 133

Showing results (1301-1310 of 1,327) with videos related to

Sort By:
Pageof 133
Journal of Hematology & Oncology|February 7, 2025
Anti-LAG-3 antibody LBL-007 plus anti-PD-1 antibody toripalimab in advanced nasopharyngeal carcinoma and other solid tumors: an open-label, multicenter, phase Ib/II trialGang Chen, Dong-Chen Sun, Yi Ba, et al.
Scientific Reports|February 17, 2018
Polygonum aviculare L. extract and quercetin attenuate contraction in airway smooth muscleXi Luo, Lu Xue, Hao Xu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2021
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 TrialShengxiang Ren, Jianhua Chen, Xingxiang Xu, et al.
Cancer Discovery|June 8, 2021
MET Amplification Attenuates Lung Tumor Response to Immunotherapy by Inhibiting STINGYong Zhang, Qifan Yang, Xiangyu Zeng, et al.
Liver Cancer|March 6, 2023
Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 TrialZhenggang Ren, Michel Ducreux, Ghassan K Abou-Alfa, et al.
Cancer Cell|February 28, 2025
Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trialCheng Xu, Guan-Qun Zhou, Wen-Fei Li, et al.
Molecular Cancer|January 4, 2022
On-treatment blood TMB as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase III trialTao Jiang, Jianhua Chen, Xingxiang Xu, et al.
Genome Biology|October 31, 2023
MGA-seq: robust identification of extrachromosomal DNA and genetic variants using multiple genetic abnormality sequencingDa Lin, Yanyan Zou, Xinyu Li, et al.
Med (New York, N.Y.)|February 14, 2026
Patient-reported outcomes from a phase 2 PLATINUM trial of nivolumab combination therapy sparing concurrent cisplatin in nasopharyngeal carcinomaCheng Xu, Ze-Qi Lin, Yu-Zhe Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2023
HLA-I Evolutionary Divergence Confers Response to PD-1 Blockade plus Chemotherapy in Untreated Advanced Non-Small Cell Lung CancerTao Jiang, Qiqi Jin, Jiahao Wang, et al.
Pageof 133